© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 14, 2022
Dr. Chopra said an FDA-approved treatment for NAFLD could come in the next 6 months.
May 13, 2022
Dr. Gerald Smetana encourages PCPs to familiarize themselves with the outpatient drug options for managing COVID-19 because of the limited treatment window for administration.
Dr. Tara Vijayan talks about how primary care physicians can be best combat misinformation.
Expert psychiatrist Dr. Timothy Fong explains the complexity of using marijuana as treatment in a primary care setting and shares advice on how to address it with patients.
Alcohol use increased during the COVID-19 pandemic, leading to an increase in alcoholic hepatitis.
High-risk individuals should be targeted when drug scarcity comes into play.
May 12, 2022
NAFLD is currently the most prevalent liver disease in the US.
Dr. Tara Vijayan speaks on improving COVID-19 treatment from “an equity standpoint, an ethical standpoint, and an evidence standpoint”.
There remains a need to develop more antivirals that can be easily scaled up for COVID-19.
May 11, 2022
At Pri-Med West, primary care providers ask Dr. Michael Ziffra and Dr. Shirah Vollmer all the questions they have about treating mental illness and prescribing different classes of drugs.
Marc Rothenberg, MD, PhD: EoE Receives First FDA Approval with Dupilumab
Systematic Review Suggests Oral JAK Inhibitors Effective in AD
Study Identifies 24 Adverse Events Associated with Secukinumab Treatment